These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1716290)

  • 21. Immunological characterization of a low molecular mass polypeptidic antigen of Borrelia burgdorferi.
    Sambri V; Moroni A; Massaria F; Brocchi E; De Simone F; Cevenini R
    FEMS Microbiol Immunol; 1991 Nov; 3(6):345-9. PubMed ID: 1725956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoblot analysis of antibody binding to polypeptides of Borrelia burgdorferi in children with different clinical manifestations of Lyme disease.
    Nadal D; Taverna C; Hitzig WH
    Pediatr Res; 1989 Oct; 26(4):377-82. PubMed ID: 2677950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi.
    Barthold SW; Feng S; Bockenstedt LK; Fikrig E; Feen K
    Clin Infect Dis; 1997 Jul; 25 Suppl 1():S9-17. PubMed ID: 9233658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Borrelia burgdorferi associated antigens by monoclonal antibodies.
    Kramer MD; Schaible UE; Wallich R; Moter SE; Petzoldt D; Simon MM
    Immunobiology; 1990 Nov; 181(4-5):357-66. PubMed ID: 2099905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein.
    Feng S; Hodzic E; Barthold SW
    Infect Immun; 2000 Jul; 68(7):4169-73. PubMed ID: 10858233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of sera from patients with Lyme disease against Borrelia burgdorferi.
    Pavia CS; Wormser GP; Norman GL
    Clin Infect Dis; 1997 Jul; 25 Suppl 1():S25-30. PubMed ID: 9233660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P55, an immunogenic but nonprotective 55-kilodalton Borrelia burgdorferi protein in murine Lyme disease.
    Feng S; Barthold SW; Telford SR; Fikrig E
    Infect Immun; 1996 Jan; 64(1):363-5. PubMed ID: 8557366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity.
    Fikrig E; Barthold SW; Sun W; Feng W; Telford SR; Flavell RA
    Immunity; 1997 May; 6(5):531-9. PubMed ID: 9175831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borrelia burgdorferi B31 Erp proteins that are dominant immunoblot antigens of animals infected with isolate B31 are recognized by only a subset of human lyme disease patient sera.
    Miller JC; El-Hage N; Babb K; Stevenson B
    J Clin Microbiol; 2000 Apr; 38(4):1569-74. PubMed ID: 10747145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and immunological characterization of a novel polymorphic lipoprotein of Borrelia burgdorferi.
    Wallich R; Simon MM; Hofmann H; Moter SE; Schaible UE; Kramer MD
    Infect Immun; 1993 Oct; 61(10):4158-66. PubMed ID: 8104894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 110-kilodalton recombinant protein which is immunoreactive with sera from humans, dogs, and horses with Lyme borreliosis.
    Caputa AC; Murtaugh MP; Bey RF; Loken KI
    J Clin Microbiol; 1991 Nov; 29(11):2418-23. PubMed ID: 1774245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoreactive epitopes on an expressed recombinant flagellar protein of Borrelia burgdorferi.
    Collins C; Peltz G
    Infect Immun; 1991 Feb; 59(2):514-20. PubMed ID: 1702766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of the humoral response to the 41-kilodalton flagellar antigen of Borrelia burgdorferi, the Lyme disease agent.
    Berland R; Fikrig E; Rahn D; Hardin J; Flavell RA
    Infect Immun; 1991 Oct; 59(10):3531-5. PubMed ID: 1894359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis.
    Yssel H; Shanafelt MC; Soderberg C; Schneider PV; Anzola J; Peltz G
    J Exp Med; 1991 Sep; 174(3):593-601. PubMed ID: 1831490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line.
    Fikrig E; Berland R; Chen M; Williams S; Sigal LH; Flavell RA
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):183-7. PubMed ID: 7678336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epitope mapping of the immunodominant invariable region of Borrelia burgdorferi VlsE in three host species.
    Liang FT; Philipp MT
    Infect Immun; 2000 Apr; 68(4):2349-52. PubMed ID: 10722641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Peptide library screening to detect a previously unknown linear diagnostic epitope: proof of principle by use of lyme disease sera.
    Hamby CV; Llibre M; Utpat S; Wormser GP
    Clin Diagn Lab Immunol; 2005 Jul; 12(7):801-7. PubMed ID: 16002626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological activity of Borrelia burgdorferi antigens.
    Benach JL; Coleman JL; Garcia-Monco JC; Deponte PC
    Ann N Y Acad Sci; 1988; 539():115-25. PubMed ID: 2461134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Borrelia burgdorferi infection and immunity in mice deficient in the fifth component of complement.
    Bockenstedt LK; Barthold S; Deponte K; Marcantonio N; Kantor FS
    Infect Immun; 1993 May; 61(5):2104-7. PubMed ID: 8478100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Borrelia burgdorferi genes selectively expressed in the infected host.
    Suk K; Das S; Sun W; Jwang B; Barthold SW; Flavell RA; Fikrig E
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4269-73. PubMed ID: 7753795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.